The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Impact of exacerbations on COPD
Open accessAbstract
Exacerbations of chronic obstructive pulmonary disease (COPD) determine disease-associated morbidity, mortality, resource burden and healthcare costs. Acute exacerbation care requirements range from unscheduled primary care visits to emergency room, inpatient or intensive care, generating significant costs in COPD. Even after an exacerbation resolves, respiratory, physical, social and emotional impairment may persist for prolonged time. Frequent exacerbations, mainly in patients with severe COPD, accelerate disease progression and mortality. Thus, patients with frequent exacerbations have a more rapid decline in lung function, worse quality of life and decreased exercise performance. Management of COPD directed to reduce incidence and severity of exacerbations improves long-term health status and conserves health care resources and costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationRabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Chronic Obstructive Pulmonary Disease
(2018) · Questions for the Final FFICM Structured Oral Examination · doi:10.1017/9781108233712.025 · Cited by 2,689
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
Soler-Cataluna, J. J. (2005) · Thorax · doi:10.1136/thx.2005.040527 · Cited by 1,931
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Tashkin, D. P., Celli, B., Senn, S., Burkhart, D., Kesten, S., Menjoge, S., & Decramer, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805800 · Cited by 1,604
Connors, A. F., Dawson, N. V., Thomas, C., Harrell, F. E., Desbiens, N., Fulkerson, W. J., Kussin, P., Bellamy, P., Goldman, L., & Knaus, W. A. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887592 · Cited by 1,393
Chronic Obstructive Pulmonary Disease Surveillance—United States, 1971–2000
Mannino, D. M., Homa, D. M., Akinbami, L. J., Ford, E. S., & Redd, S. C. (2002) · Respiratory Care · doi:10.1177/002013240204701009 · Cited by 1,294
Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
Garcia-Aymerich, J., Lange, P., Benet, M., Schnohr, P., & Anto, J. M. (2006) · Thorax · doi:10.1136/thx.2006.060145 · Cited by 1,113
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations
Papi, A., Bellettato, C. M., Braccioni, F., Romagnoli, M., Casolari, P., Caramori, G., Fabbri, L. M., & Johnston, S. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200506-859oc · Cited by 1,072
Celli, B. R., Thomas, N. E., Anderson, J. A., Ferguson, G. T., Jenkins, C. R., Jones, P. W., Vestbo, J., Knobil, K., Yates, J. C., & Calverley, P. M. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1869oc · Cited by 748
Mortality and Mortality-Related Factors After Hospitalization for Acute Exacerbation of COPD
Groenewegen, K. H., Schols, A. M. W. J., & Wouters, E. F. M. (2003) · Chest · doi:10.1378/chest.124.2.459 · Cited by 717
Physical Activity and Hospitalization for Exacerbation of COPD
Pitta, F., Troosters, T., Probst, V. S., Spruit, M. A., Decramer, M., & Gosselink, R. (2006) · Chest · doi:10.1378/chest.129.3.536 · Cited by 688
Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, C. O., Olivieri, D., Del Donno, M., De Backer, W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66456-2 · Cited by 684
Mortality after hospitalization for COPD
Almagro, P., Calbo, E., Ochoa de Echaguïen, A., Barreiro, B., Quintana, S., Heredia, J. L., & Garau, J. (2002) · Chest · doi:10.1378/chest.121.5.1441 · Cited by 630
Miravitlles, M. (2004) · Thorax · doi:10.1136/thx.2003.008730 · Cited by 557
Efficacy of Salmeterol Xinafoate in the Treatment of COPD
Mahler, D. A., Donohue, J. F., Barbee, R. A., Goldman, M. D., Gross, N. J., Wisniewski, M. E., Yancey, S. W., Zakes, B. A., Rickard, K. A., & Anderson, W. H. (1999) · Chest · doi:10.1378/chest.115.4.957 · Cited by 520
Paggiaro, P. L., Dahle, R., Bakran, I., Frith, L., Hollingworth, K., & Efthimiou, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)03471-5 · Cited by 508
Decramer, M., Celli, B., Kesten, S., Lystig, T., Mehra, S., & Tashkin, D. P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61298-8 · Cited by 495
Stanescu, D., Sanna, A., Veriter, C., Kostianev, S., Calcagni, P. G., Fabbri, L. M., & Maestrelli, P. (1996) · Thorax · doi:10.1136/thx.51.3.267 · Cited by 462
Niewoehner, D. E., Rice, K., Cote, C., Paulson, D., Cooper, J. A. D., Korducki, L., Cassino, C., & Kesten, S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00007 · Cited by 436
C-reactive protein in patients with COPD, control smokers and non-smokers
Pinto-Plata, V. M. (2005) · Thorax · doi:10.1136/thx.2005.042200 · Cited by 435
Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease
Antonelli Incalzi, R., Fuso, L., De Rosa, M., Forastiere, F., Rapiti, E., Nardecchia, B., & Pistelli, R. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10122794 · Cited by 404
(2007) · Obstructive Sleep Apnea: Pathophysiology, Comorbidities and Consequences · doi:10.3109/9781420020458-18 · Cited by 361
Zheng, J.-P., Kang, J., Huang, S.-G., Chen, P., Yao, W.-Z., Yang, L., Bai, C.-X., Wang, C.-Z., Wang, C., Chen, B.-Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60869-7 · Cited by 358
Jenkins, C. R., Jones, P. W., Calverley, P. M., Celli, B., Anderson, J. A., Ferguson, G. T., Yates, J. C., Willits, L. R., & Vestbo, J. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-59 · Cited by 345
Miravitlles, M., Guerrero, T., Mayordomo, C., Sánchez-Agudo, L., Nicolau, F., & Segú, J. L. (2000) · Respiration · doi:10.1159/000067462 · Cited by 335
Health Status Deterioration in Patients with Chronic Obstructive Pulmonary Disease
SPENCER, S., CALVERLEY, P. M. A., SHERWOOD BURGE, P., & JONES, P. W. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2005009 · Cited by 334
Time course of recovery of health status following an infective exacerbation of chronic bronchitis
Spencer, S. (2003) · Thorax · doi:10.1136/thorax.58.7.589 · Cited by 331
Hanania, N. A., Darken, P., Horstman, D., Reisner, C., Lee, B., Davis, S., & Shah, T. (2003) · Chest · doi:10.1378/chest.124.3.834 · Cited by 327
Exacerbations and Time Spent Outdoors in Chronic Obstructive Pulmonary Disease
Donaldson, G. C., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., & Wedzicha, J. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1054oc · Cited by 316
Tillie-Leblond, I., Marquette, C.-H., Perez, T., Scherpereel, A., Zanetti, C., Tonnel, A.-B., & Remy-Jardin, M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00005 · Cited by 312
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Gompertz, S., O'Brien, C., Bayley, D. L., Hill, S. L., & Stockley, R. A. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.99114901 · Cited by 292
The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review
Stey, C., Steurer, J., Bachmann, S., Medici, T. C., & Tramèr, M. R. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16b12.x · Cited by 284
Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD
Miravitlles, M., Murio, C., Guerrero, T., & Gisbert, R. (2002) · Chest · doi:10.1378/chest.121.5.1449 · Cited by 283
Fuso, L., Antonelli Incalzi, R., Pistelli, R., Muzzolon, R., Valente, S., Pagliari, G., Gliozzi, F., & Ciappi, G. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80374-x · Cited by 272
Grandjean, E. M., Berthet, P., Ruffmann, R., & Leuenberger, P. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88479-9 · Cited by 270
DAHL, M., TYBJŒRG-HANSEN, A., VESTBO, J., LANGE, P., & NORDESTGAARD, B. G. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.6.2010067 · Cited by 260
Patient Understanding, Detection, and Experience of COPD Exacerbations
Kessler, R., Ståhl, E., Vogelmeier, C., Haughney, J., Trudeau, E., Löfdahl, C.-G., & Partridge, M. R. (2006) · Chest · doi:10.1378/chest.130.1.133 · Cited by 255
Impact of COPD Exacerbations on Patient-Centered Outcomes
Cote, C. G., Dordelly, L. J., & Celli, B. R. (2007) · Chest · doi:10.1378/chest.06-1610 · Cited by 250
Respiratory Viral Infections in Adults With and Without Chronic Obstructive Pulmonary Disease
GREENBERG, S. B., ALLEN, M., WILSON, J., & ATMAR, R. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.1.9911019 · Cited by 246
Dewan, N. A., Rafique, S., Kanwar, B., Satpathy, H., Ryschon, K., Tillotson, G. S., & Niederman, M. S. (2000) · Chest · doi:10.1378/chest.117.3.662 · Cited by 237
Crooks, S. W., Bayley, D. L., Hill, S. L., & Stockley, R. A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.15b09.x · Cited by 235
Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
Ferguson, G. T., Anzueto, A., Fei, R., Emmett, A., Knobil, K., & Kalberg, C. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.04.019 · Cited by 232
Self-citationAntibiotics Are Associated With Lower Relapse Rates in Outpatients With Acute Exacerbations of COPD
Adams, S. G., Melo, J., Luther, M., & Anzueto, A. (2000) · Chest · doi:10.1378/chest.117.5.1345 · Cited by 228
Self-citationMucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
Poole, P., Black, P. N., & Cates, C. J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001287.pub4 · Cited by 225
Airway Inflammation and Etiology of Acute Exacerbations of Chronic Bronchitis
Sethi, S., Muscarella, K., Evans, N., Klingman, K. L., Grant, B. J. B., & Murphy, T. F. (2000) · Chest · doi:10.1378/chest.118.6.1557 · Cited by 219
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Eagan, T. M. L., Ueland, T., Wagner, P. D., Hardie, J. A., Mollnes, T. E., Damås, J. K., Aukrust, P., & Bakke, P. S. (2010) · European Respiratory Journal · doi:10.1183/09031936.00088209 · Cited by 207
ZHU, J., QIU, Y. S., MAJUMDAR, S., GAMBLE, E., MATIN, D., TURATO, G., FABBRI, L. M., BARNES, N., SAETTA, M., & JEFFERY, P. K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.1.2007050 · Cited by 203
Hopkinson, N. S., Tennant, R. C., Dayer, M. J., Swallow, E. B., Hansel, T. T., Moxham, J., & Polkey, M. I. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-25 · Cited by 202
Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice
Miravitlles, M., Mayordomo, C., Artés, M., Sánchez-Agudo, L., Nicolau, F., & Segu, J.-L. (1999) · Respiratory Medicine · doi:10.1016/s0954-6111(99)90004-5 · Cited by 191
Gompertz, S. (2001) · Thorax · doi:10.1136/thorax.56.1.36 · Cited by 184
Anzueto, A., Ferguson, G. T., Feldman, G., Chinsky, K., Seibert, A., Emmett, A., Knobil, K., O'Dell, D., Kalberg, C., & Crater, G. (2009) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903140881 · Cited by 172
Self-citationImpact of statins and ACE inhibitors on mortality after COPD exacerbations
Mortensen, E. M., Copeland, L. A., Pugh, M. J. V., Restrepo, M. I., de Molina, R. M., Nakashima, B., & Anzueto, A. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-45 · Cited by 170
Self-citationImpact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes
Kesten, S. (2009) · International Journal of COPD · doi:10.2147/copd.s4862 · Cited by 140
Gottlieb, D. J., Stone, P. J., Sparrow, D., Gale, M. E., Weiss, S. T., Snider, G. L., & O’Connor, G. T. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912738 · Cited by 134
The burden of COPD in the U.S.A.: results from the confronting COPD survey
Halpern, M. T., Stanford, R. H., & Borker, R. D. (2003) · Respiratory Medicine · doi:10.1016/s0954-6111(03)80028-8 · Cited by 134
Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year
Xu, W., Collet, J., Shapiro, S., Lin, Y., Yang, T., Wang, C., & Bourbeau, J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00079409 · Cited by 132
Aaron, S. D., Vandemheen, K. L., Clinch, J., Ahuja, J., Brison, R. J., Dickinson, G. E., & Hébert, P. C. (2002) · CHEST Journal · doi:10.1378/chest.121.3.688 · Cited by 124
Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease?
Rutschmann, O. T., Cornuz, J., Poletti, P., Bridevaux, P., Hügli, O., Qanadli, S. D., & Perrier, A. (2006) · Thorax · doi:10.1136/thx.2006.065557 · Cited by 117
C-reactive protein in patients with COPD, control smokers and non-smokers
Pinto-Plata, V., Müllerová, H., Toso, J. F., Feudjo-Tepie, M. A., Soriano, J. B., Vessey, R., & Celli, B. R. (2006) · Respiratory Medicine COPD Update · doi:10.1016/j.rmedu.2006.01.015 · Cited by 97
Economic burden of chronic obstructive pulmonary disease
TEO, W. ‐. K., Tan, W. S., CHONG, W., Abisheganaden, J. A., Lew, Y.-J., LIM, T., & Heng, B. H. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02073.x · Cited by 90
Vílkman, S., Keistinen, T., Tuuponen, T., & Kivelä, S. (2009) · Respiration · doi:10.1159/000196687 · Cited by 83
Piehl‐Aulin, K., Jones, I. R., Lindvall, B., Magnuson, A., & Abdel‐Halim, S. M. (2009) · Respiration · doi:10.1159/000207793 · Cited by 77
Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling
Haughney, J., Partridge, M. R., Vogelmeier, C. F., Larsson, T. P., Kessler, R., Ståhl, E., Brice, R., & Lofdahl, C. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00142704 · Cited by 66
Decramer, M., & Janssens, W. (2010) · European Respiratory Review · doi:10.1183/09059180.00003610 · Cited by 41
ERSSON, I., Johansson, K. M., Larsson, S., & Pehrsson, K. (2002) · Respiratory Medicine · doi:10.1053/rmed.2002.1370 · Cited by 30
Murata, G. H., Gorby, M. S., Kapsner, C. O., et al. (1992) · PubMed · Cited by 26
Prevention of exacerbations of COPD with pharmacotherapy
Miravitlles, M. (2010) · European Respiratory Review · doi:10.1183/09059180.00002810 · Cited by 19
Cited by
The versatile use of exhaled volatile organic compounds in human health and disease
Boots, A. W., van Berkel, J. J. B. N., Dallinga, J. W., Smolinska, A., Wouters, E. F., & van Schooten, F. J. (2012) · Journal of Breath Research · doi:10.1088/1752-7155/6/2/027108 · Cited by 352
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
Pavord, I. D., Lettis, S., Locantore, N., Pascoe, S., Jones, P. W., Wedzicha, J. A., & Barnes, N. C. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207021 · Cited by 327
Gong, Y., Xu, C., Mo, C., Wu, J., Lin, H., Su, H., Zhang, Q., Zhang, Q., & Yang, S. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02086-z · Cited by 6
Metadata
- Authors
- Anzueto, A.
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2010-05-31
- Volume
- 19
- Issue
- 116
- Pages
- 113-118
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- OpenAlex
- W2136394058
- Cited by
- 353
- References
- 73
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.